Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures

References

• Steinlein OK, Mulley JC, Propping P et al. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet.11, 201–203 (1995).
   PubMed Web of Science ®Google Scholar
• Hirose S, Iwata H, Akiyoshi H et al. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology53, 1749–1753 (1999).
   PubMed Web of Science ®Google Scholar
• Steinlein OK, Magnusson A, Stoodt J et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet.6, 943–947 (1997).
   PubMed Web of Science ®Google Scholar
• Leniger T, Kananura C, Hufnagel A, Bertrand S, Bertrand D, Steinlein OK. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia44, 981–985 (2003).
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu L, Fang Y et al. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. Epilepsy Res.83, 152–156 (2009).
   Google Scholar
• De Fusco M, Becchetti A, Patrignani A et al. The nicotinic receptor β 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat. Genet.26, 275–276 (2000).
   PubMed Web of Science ®Google Scholar
• McLellan A, Phillips HA, Rittey C et al. Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia44, 613–617 (2003).
   Google Scholar
• Hoda JC, Gu W, Friedli M et al. Human nocturnal frontal lobe epilepsy, pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor β-subunit mutations outside the ion channel pore. Mol. Pharmacol.74, 379–391 (2008).
   PubMedGoogle Scholar
• Bertrand D, Elmslie F, Hughes E et al. The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol. Dis.20, 799–804 (2005).
   PubMed Web of Science ®Google Scholar
• Aridon P, Marini C, Di Resta C et al. Increased sensitivity of the neuronal nicotinic receptor α 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am. J. Hum. Genet.79, 342–350 (2006).
   PubMed Web of Science ®Google Scholar
• Phillips HA, Marini C, Scheffer IE, Sutherland GR, Mulley JC, Berkovic SF. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann. Neurol.48, 264–267 (2000).
   PubMed Web of Science ®Google Scholar
• Cho YW, Motamedi GK, Laufenberg I et al. A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. Arch. Neurol.60, 1625–1632 (2003).
   Google Scholar
• Magnusson A, Stordal E, Brodtkorb E, Steinlein O. Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. Psychiatr. Genet.13, 91–95 (2003).
   PubMed Web of Science ®Google Scholar
• Bertrand D, Picard F, le Hellard S et al. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia43(Suppl. 5), 112–122 (2002).
   PubMedGoogle Scholar
• Baraban SC. Emerging epilepsy models, insights from mice, flies, worms and fish. Curr. Opin. Neurol.20, 64–68 (2007).
   Google Scholar
• Bugos O, Bhide M, Zilka N. Beyond the rat models of human neurodegenerative disorders. Cell. Mol. Neurobiol.29, 859–869 (2009).
   Google Scholar
• Canzian F. Phylogenetics of the laboratory rat Rattus norvegicus. Genome Res.7, 262–267 (1997).
   Google Scholar
• Tesson L, Cozzi J, Menoret S et al. Transgenic modifications of the rat genome. Transgenic Res.14, 531–546 (2005).
   Web of Science ®Google Scholar
• Li P, Tong C, Mehrian-Shai R et al. Germline competent embryonic stem cells derived from rat blastocysts. Cell135, 1299–1310 (2008).
   PubMed Web of Science ®Google Scholar
• Aitman TJ, Critser JK, Cuppen E et al. Progress and prospects in rat genetics, a community view. Nat. Genet.40, 516–522 (2008).
   PubMed Web of Science ®Google Scholar
• Wall RJ. New gene transfer methods. Theriogenology57, 189–201 (2002).
   PubMed Web of Science ®Google Scholar
• Cohen G, Han ZY, Grailhe R et al. β 2 nicotinic acetylcholine receptor subunit modulates protective responses to stress, a receptor basis for sleep-disordered breathing after nicotine exposure. Proc. Natl Acad. Sci. USA99, 13272–13277 (2002).
   Google Scholar
• Marubio LM, del Mar Arroyo-Jimenez M et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature398, 805–810 (1999).
   PubMed Web of Science ®Google Scholar
• Picciotto MR, Zoli M, Rimondini R et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature391, 173–177 (1998).
   PubMed Web of Science ®Google Scholar
• Ross SA, Wong JY, Clifford JJ et al. Phenotypic characterization of an α 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J. Neurosci.20, 6431–6441 (2000).
   PubMed Web of Science ®Google Scholar
• Wong JY, Ross SA, McColl C et al. Proconvulsant-induced seizures in α (4) nicotinic acetylcholine receptor subunit knockout mice. Neuropharmacology43, 55–64 (2002).
   Google Scholar
• McColl CD, Horne MK, Finkelstein DI, Wong JY, Berkovic SF, Drago J. Electroencephalographic characterisation of pentylenetetrazole-induced seizures in mice lacking the α 4 subunit of the neuronal nicotinic receptor. Neuropharmacology44, 234–243 (2003).
   Google Scholar
• Klaassen A, Glykys J, Maguire J, Labarca C, Mody I, Boulter J. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc. Natl Acad. Sci. USA103, 19152–19157 (2006).
   PubMed Web of Science ®Google Scholar
• Teper Y, Whyte D, Cahir E et al. Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation. J. Neurosci.27, 10128–10142 (2007).
   Google Scholar
• Manfredi I, Zani AD, Rampoldi L et al. Expression of mutant β2 nicotinic receptors during development is crucial for epileptogenesis. Hum. Mol. Genet.18, 1075–1088 (2009).
   Google Scholar
• Zhu G, Okada M, Yoshida S et al. Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype. J. Neurosci.28, 12465–12476 (2008).
   Google Scholar
• Mulle C, Léna C, Changeux JP. Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron8, 937–945 (1992).
   PubMed Web of Science ®Google Scholar
• Vernino S, Amador M, Luetje CW, Patrick J, Dani JA. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron8, 127–134 (1992).
   PubMed Web of Science ®Google Scholar
• Liu QS, Berg DK. Extracellular calcium regulates responses of both α3- and α7-containing nicotinic receptors on chick ciliary ganglion neurons. J. Neurophysiol.82, 1124–1132 (1999).
   Google Scholar
• Rodrigues-Pinguet N, Jia L, Li M et al. Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian α4β2 acetylcholine response. J. Physiol.550, 11–26 (2003).
   Google Scholar
• Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, Bertrand D. Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells, a patch-clamp study. J. Neurosci.16, 7880–7891 (1996).
   Google Scholar
• Rodrigues-Pinguet NO, Pinguet TJ, Figl A, Lester HA, Cohen BN. Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the α 4 β 2 nicotinic acetylcholine receptor. Mol. Pharmacol.68, 487–501 (2005).
   PubMedGoogle Scholar
• Le Novère N, Grutter T, Changeux JP. Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites. Proc. Natl Acad. Sci. USA99, 3210–3215 (2002).
   PubMed Web of Science ®Google Scholar
• Scheffer IE, Bhatia KP, Lopes-Cendes I et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain118, 61–73 (1995).
   PubMed Web of Science ®Google Scholar
• Hayden EC. Human genome at ten, life is complicated. Nature464, 664–667 (2010).
   Web of Science ®Google Scholar
• Oliveri P, Tu Q, Davidson EH. Global regulatory logic for specification of an embryonic cell lineage. Proc. Natl Acad. Sci. USA105, 5955–5962 (2008).
   PubMedGoogle Scholar
• Bargmann CI. Neurobiology of the Caenorhabditis elegans genome. Science282, 2028–2033 (1998).
   PubMed Web of Science ®Google Scholar
• Kamath RS, Fraser AG, Dong AG. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature421, 231–237 (2003).
   PubMed Web of Science ®Google Scholar
• Kim JK, Gabel HW, Kamath RS et al. Functional genomic analysis of RNA interference in C. elegans. Science308, 1164–1167 (2005).
   PubMedGoogle Scholar
• Nonet ML. Visualization of synaptic specializations in live C. elegans with synaptic vesicle protein–GFP fusions. J. Neurosci. Methods89, 33–40 (1999).
   PubMedGoogle Scholar
• Williams SN, Locke CJ, Braden AL, Caldwell KA, Caldwell GA. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans. Hum. Mol. Genet.13, 2043–2059 (2004).
   PubMedGoogle Scholar
• Brenner S. The genetics of Caenorhabditis elegans. Genetics77, 71–94 (1974).
   PubMed Web of Science ®Google Scholar
• Jospin M, Qi YB, Stawicki TM et al. A neuronal acetylcholine receptor regulates the balance of muscle excitation and inhibition in Caenorhabditis elegans. PLoS Biol.7(12), e1000265 (2009).
   PubMedGoogle Scholar
• Reiner DJ, Newton EM, Tian H, Thomas JH. Diverse behavioural defects caused by mutations in Caenorhabditis elegans unc-43 CaM kinase II. Nature402, 199–203 (1999).
   PubMedGoogle Scholar
• Phelps HA, Neely MN. Evolution of the zebrafish model, from development to immunity and infectious disease. Zebrafish2, 87–103 (2005).
   Google Scholar
• Baraban SC, Dinday MT, Castro PA, Chege S, Guyenet S, Taylor MR. A large-scale mutagenesis screen to identify seizure-resistant zebrafish. Epilepsia48, 1151–1157 (2007).
   PubMed Web of Science ®Google Scholar
• Baraban SC, Taylor MR, Castro PA, Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience131, 759–768 (2005).
   PubMed Web of Science ®Google Scholar
• Ekker SC. Morphants, a new systematic vertebrate functional genomics approach. Yeast17, 302–306 (2000)
   PubMed Web of Science ®Google Scholar
• Corey DR, Abrams JM. Morpholino antisense oligonucleotides, tools for investigating vertebrate development. Genome Biol.2(5), 1015 (2001).
   Google Scholar